Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy
Recruiting
Observational Study
Prostate Cancer (Post Prostatectomy)
Prostate Cancer (Adenocarcinoma)
Prostate Cancer (Diagnosis)
Prostate Specific Antigen
Radical Prostatectomy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Lithuanian University of Health Sciences · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective observational study aims to evaluate the prognostic significance of early postoperative prostate-specific antigen (PSA) levels in patients undergoing radical prostatectomy for prostate cancer.
No investigational interventions will be performed. All diagnostic procedures, follow-up assessments, and treatments will be conducted in accordance with standard clinical practice and esta…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient is an adult biological male.
* Patient has morphologically confirmed and untreated prostate cancer.
* Patient who will be treated with open, laparoscopic or robot-assisted laparoscopic radical prostatectomy.
* Patient is informed about this observational study and has …
Contacts